Extracellular vesicles beyond biomarkers: Effectors of antibody-mediated rejection
- PMID: 35776663
- DOI: 10.1111/ajt.17133
Extracellular vesicles beyond biomarkers: Effectors of antibody-mediated rejection
Comment on
-
Extracellular vesicles derived from patients with antibody-mediated rejection induce tubular senescence and endothelial to mesenchymal transition in renal cells.Am J Transplant. 2022 Sep;22(9):2139-2157. doi: 10.1111/ajt.17097. Epub 2022 Jul 5. Am J Transplant. 2022. PMID: 35583104 Free PMC article.
References
REFERENCES
-
- Franzin R, Stasi A, Sallustio F, et al. Extracellular vesicles derived from patients with antibody-mediated rejection induce tubular senescence and endothelial to mesenchymal transition in renal cells. Am J Transplant. 2022; IN PRESS.
-
- Doreille A, Dieude M, Cardinal H. The determinants, biomarkers, and consequences of microvascular injury in kidney transplant recipients. Am J Physiol Renal Physiol. 2019;316(1):F9-F19.
-
- Good ME, Musante L, La Salvia S, et al. Circulating extracellular vesicles in Normotension restrain vasodilation in resistance arteries. Hypertension. 2020;75(1):218-228.
-
- Zhang H, Lin S, McElroy CL, et al. Circulating pro-inflammatory exosomes worsen stroke outcomes in aging. Circ Res. 2021;129(7):e121-e140.
-
- Dieude M, Bell C, Turgeon J, et al. The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection. Sci Transl Med. 2015;7(318):318ra200.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources